Mode
Text Size
Log in / Sign up

Sex, age, and body size predict exercise capacity in Fontan patients more than anatomical or surgical factors

Sex, age, and body size predict exercise capacity in Fontan patients more than anatomical or surgica…
Photo by Cht Gsml / Unsplash
Key Takeaway
Consider that exercise limitations in Fontan patients may relate more to progressive pathophysiology than specific anatomical features.

This multicenter cohort study analyzed 561 individuals with Fontan circulation (mean age 20 ± 8 years, 54% male) from the Single Ventricle Outcomes Network database. Researchers examined the relationship between anatomical, diagnostic, and surgical factors and exercise capacity measured by percent predicted peak oxygen consumption (%pVO2), using published reference equations for comparison.

The strongest predictors of %pVO2 were sex (females had 12% higher values than males) and exercise modality (treadmill testing showed 4.6% higher values than cycle ergometry). Age at cardiopulmonary exercise testing was also a predictor, with %pVO2 decreasing by 0.8% per year. In contrast, ventricular morphology, underlying diagnosis, Fontan subtype, and conduit diameter showed no statistically significant association with exercise capacity. Univariable nonlinear spline analyses suggested an optimal conduit size of 18 mm, but this finding was not significant after adjusting for body size.

No safety or tolerability data were reported. The study's main limitation is that data explaining variability in exercise capacity remain limited. These observational findings suggest that reduced exercise capacity in Fontan patients may reflect progressive pathophysiological changes rather than specific anatomical or surgical characteristics. Clinicians should interpret these results cautiously as they cannot establish causality.

Study Details

Study typeCohort
Sample sizen = 330
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Background Exercise capacity varies among individuals with a Fontan circulation. Percent predicted peak oxygen consumption (%pVO2) may be influenced by ventricular morphology, Fontan subtype, and conduit characteristics, but data explaining variability in exercise capacity are limited. This study examined whether anatomical and surgical factors are associated with %pVO2 later in life. Methods Participants enrolled in the multicenter Single Ventricle Outcomes Network (SV-ONE) database who had cardiopulmonary exercise testing (CPET) data were included. Published reference equations were used to estimate %pVO2. Multivariable regression models evaluated associations between anthropometric, anatomical (diagnosis and dominant ventricle), and surgical (Fontan subtype, conduit size, and surgical era) factors and %pVO2. Restricted spline analyses assessed nonlinearity. Results 561 individuals with a Fontan circulation were included in the analysis; age 20 {+/-} 8 years, 54% male, mean %pVO2 was 63 {+/-} 16%. Sex and exercise modality were the strongest predictors of %pVO2, with females being 12% higher than males and treadmill 4.6% higher than a cycle. Age at CPET was a predictor of exercise capacity with %pVO2 decreasing by 0.8% per year. Ventricular morphology, diagnosis, and Fontan subtype did not have a statistical association with the primary outcome. In models restricted to patients with an extracardiac conduit (n = 330), conduit diameter and area were not associated with %pVO2, even after indexing to body surface area. Univariable nonlinear spline analyses suggested an optimal conduit size of 18 mm for %pVO2, but this was not significant after body size adjustments. Conclusion In this large multicenter cohort, surgical and anatomical features were not as important as sex, age, and body size as determinants of exercise performance in patients with a Fontan circulation. Reduced exercise capacity in this population appears to reflect progressive pathophysiological changes of the Fontan circulation rather than specific characteristics such as conduit size, ventricular morphology, or anatomy.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.